Search
Enveric Biosciences Inc
ENVBAdd to Watchlist
1.520USD
+0.010+0.66%
Close 08-13 16:00（ET）Quotes delayed by 15 min
2.87MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-13No earnings forecast score is currently available for Enveric Biosciences Inc. The Biotechnology & Medical Research industry's average is 8.10. The average price target is 120.00, with a high of 120.00 and a low of 120.00.
Analyst Rating
Based on
0
analysts
--
Current Rating
120.000
Target Price
+5960.61%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Enveric Biosciences Inc
ENVB
0
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Enveric Biosciences Inc's price target?
Analysts forecast that Enveric Biosciences Inc's price target is USD 120.00, with the highest forecast at USD 120.00 and the lowest forecast at USD 120.00.